The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
Official Title: A Randomized, Single-blind, Placebo-controlled, Multicentre Study to Evaluate the Effect of Risedronate and Placebo on Bone Mineral Density in Men Undergoing Androgen Deprivation Therapy With Leuprolide Acetate
Study ID: NCT00426777
Brief Summary: Prostate cancer patients treated with LHRH agonists (e.g., leuprolide) lose bone mineral density. This is similar to post-menopausal osteoporosis. Risedronate is approved to prevent osteoporosis. We hypothesize that risedronate may also be effective in prostate cancer patients treated with LHRH agonists.
Detailed Description: IV bisphosphonates have proven effective in treating bone loss in prostate cancer patients treated with LHRH agonists. However, it is yet to be determined if an oral bisphosphonate such as risedronate could offer the same benefits.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Southern Interior Medical Research Corporation, Kelowna, British Columbia, Canada
Dr. Cal Andreou, Surrey, British Columbia, Canada
Dr. Allan Patrick, Fredericton, New Brunswick, Canada
The Male/Female Health and Research Centre, Barrie, Ontario, Canada
Dr. Stanley Flax, Brampton, Ontario, Canada
Brantford Urology Research, Medical Arts Building, Brantford, Ontario, Canada
G. Kenneth Jansz Medicine Professional Corporation, Burlington, Ontario, Canada
Urology Research Centre, Burlington, Ontario, Canada
Guelph Urology Associates, Guelph, Ontario, Canada
Credit Valley Medical Arts Centre, Mississauga, Ontario, Canada
Mor Urology Inc., Bayview Business Centre, Newmarket, Ontario, Canada
The Male and Female Health Centre, Oakville, Ontario, Canada
Orillia Urology Associates, Orillia, Ontario, Canada
Urotec, Oshawa, Ontario, Canada
Dr. Todd Webster, Owen Sound, Ontario, Canada
Kawartha Urology Associates, Peterborough, Ontario, Canada
Dr. Allan Abramovitch, Scarborough, Ontario, Canada
Northern Urology Centre, Sudbury, Ontario, Canada
The Male Health Centre, Toronto, Ontario, Canada
Dr. Roger J. Buckley, Willowdale, Ontario, Canada
Urology South Shore Research, Greenfield Park, Quebec, Canada
Name: Richard W Casey, M.D.
Affiliation: CMX Research
Role: PRINCIPAL_INVESTIGATOR